| Literature DB >> 29551590 |
Camila Rubio-Patiño1, Jozef P Bossowski1, Gian Marco De Donatis1, Laura Mondragón1, Elodie Villa1, Lazaro E Aira1, Johanna Chiche1, Rana Mhaidly1, Cynthia Lebeaupin1, Sandrine Marchetti1, Konstantinos Voutetakis2, Aristotelis Chatziioannou3, Florence A Castelli4, Patricia Lamourette4, Emeline Chu-Van4, François Fenaille4, Tony Avril5, Thierry Passeron1, John B Patterson6, Els Verhoeyen1, Béatrice Bailly-Maitre1, Eric Chevet5, Jean-Ehrland Ricci7.
Abstract
Dietary restriction (DR) was shown to impact on tumor growth with very variable effects depending on the cancer type. However, how DR limits cancer progression remains largely unknown. Here, we demonstrate that feeding mice a low-protein (Low PROT) isocaloric diet but not a low-carbohydrate (Low CHO) diet reduced tumor growth in three independent mouse cancer models. Surprisingly, this effect relies on anticancer immunosurveillance, as depleting CD8+ T cells, antigen-presenting cells (APCs), or using immunodeficient mice prevented the beneficial effect of the diet. Mechanistically, we established that a Low PROT diet induces the unfolded protein response (UPR) in tumor cells through the activation of IRE1α and RIG1 signaling, thereby resulting in cytokine production and mounting an efficient anticancer immune response. Collectively, our data suggest that a Low PROT diet induces an IRE1α-dependent UPR in cancer cells, enhancing a CD8-mediated T cell response against tumors.Entities:
Keywords: ER stress; IRE1α; RIG1; UPR; anti-tumor immunity; cancer; diet; dietary restriction; immunosurveillance
Mesh:
Substances:
Year: 2018 PMID: 29551590 DOI: 10.1016/j.cmet.2018.02.009
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287